4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-026232
$NBYCIK 0001389545operating
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:08 PM ET
Size
4.8 KB
Accession
0001437749-16-026232
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-02-25$1.91/sh+125,387$239,489→ 133,246 total
Footnotes (3)
- [F1]share ownership reflects the 25:1 reverse split effectuated by the company in December 2015
- [F2]Share acquisition pursuant to a securities purchase agreement, which is one of three securities purchase agreements that the company entered into for the sale of an aggregate of 1,518,567 shares of the Company's common stock to accredited investors.
- [F3]Price is equivalent to the closing price of one share of NovaBay common stock on the day the securities purchase agreement was signed, February 16, 2016.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:08 PM ET
- Size
- 4.8 KB